Chip Selloff and Gulf Strikes: Week Review June 2026

The last time a trillion-dollar chip selloff coincided with an active military exchange in the Persian Gulf was, well, never, at least not at this scale. But the closest rhyme might be Q4 2018, when the Fed was hiking into slowing data while trade war headlines hammered sentiment. Back then, the S&P 500 lost about 20% in a quarter before a sharp reversal once the Fed pivoted. The parallel is loose, but the shared ingredient is the same: multiple sources of stress hitting at once, with investors struggling to price them simultaneously.

This week made that task harder, not easier.

What the Week Actually Revealed

Let me start with the number that anchors everything: the S&P 500 Information Technology sector fell 5.78% for the week. That is the sharpest weekly tech drawdown I have flagged in months, and it pulled the broader S&P 500 down 2.64% and the Nasdaq Composite down 4.18%. Headlines about a chip selloff erasing over a trillion dollars in market value were not exaggeration. They were arithmetic.

Why did chips sell off? A few threads tangled together, and the causal chain is worth tracing carefully.

First, Anthropic publicly urged AI labs to pause development, warning that humans risk losing control. Whether you agree with the substance or not, the statement introduces a new category of regulatory risk for companies whose valuations depend on accelerating AI deployment. If "pause" becomes a policy idea that gains traction in Washington or Brussels, it directly threatens the demand curve that justifies semiconductor capex.

Second, China's announcement that it is building what amounts to an economic fortress, tightening national security controls that could complicate overseas growth for Chinese tech firms, lands directly on the semiconductor supply chain. When your biggest growth market and your biggest supply chain risk are the same geography, any headline about tightening controls matters.

And here is the counterpoint that complicates a pure doom narrative: Marvell Technology was announced as joining the S&P 500 this week after its AI-driven boom helped it pass the index's profitability test. A chipmaker being elevated into the benchmark during a trillion-dollar sector rout is a reminder that the selloff was not about fundamentals collapsing across the board. It was about a repricing of regulatory and geopolitical risk in a sector that had run very far, very fast. The stocks that sold hardest were those with the longest-duration, most speculative AI-dependent earnings. Companies that have already proven profitability were treated differently.

Then there is the Gulf. As I discussed in Gulf Conflict at Day 98: Oman Disruption, Asian Equity Stress, and the U.S. Defensive Rotation, the ongoing conflict between the U.S. and Iran has been a slow-burning source of equity stress, particularly in Asia. This week's exchange of strikes, with the U.S. hitting Iranian drones and radar sites and Tehran targeting bases in Kuwait and Bahrain, escalated the tension another notch. The transmission mechanism matters here: Gulf military risk feeds directly into energy supply uncertainty, which raises the inflation risk premium embedded in bond yields, which in turn pressures long-duration growth stocks and rate-sensitive small caps. It is not just "geopolitics = bad." It is a specific chain: Gulf instability pushes oil risk premiums higher, inflation expectations become stickier, the Fed stays hawkish longer, and the discount rate on future earnings goes up.

That chain hit Asian markets hardest. South Korea's KOSPI fell 5.54% for the week. The South Korea ETF, EWY, dropped 14.11%, a gap that likely reflects currency effects and ETF-specific liquidity dynamics on top of the underlying index move. Taiwan's benchmark TWII fell 1.33%, though the Taiwan ETF EWT dropped 7.25%, again a notable discrepancy that suggests dollar-denominated ETF holders were pricing in additional currency and geopolitical risk beyond what the local index captured. These Asian export economies sit at the intersection of semiconductor supply chains and Gulf energy dependence, absorbing both shocks at once.

Meanwhile, European markets sharply outperformed, though the picture was not uniformly positive. The FTSE was essentially flat, up 0.08%. Spain's IBEX rose 0.38%. Switzerland's SMI gained 0.35%. But the DAX fell 0.75%, the CAC 40 dipped 0.32%, and the Euro Stoxx 50 lost 0.68%. So "Europe barely flinched" is an overstatement. The more precise read is that European markets dramatically outperformed the U.S. and Asia, with lower-beta, less tech-heavy markets holding up best. The defensive rotation pattern I flagged in recent posts, where capital flows toward lower-beta markets during stress, played out clearly this week. As explored in What Is Sector Rotation and How Smart Money Moves Between Industries, this kind of systematic capital movement between sectors and geographies is one of the most important forces driving short-term market variation.

One European development worth noting: Austria was downgraded this week, ending its era in the club of Europe's safest sovereign borrowers. While this did not visibly move equity markets, it adds a data point to the broader rates picture. When even traditionally safe European sovereigns face credit pressure, it reinforces the theme of persistent global fiscal strain and higher-for-longer yields.

And rates? KPMG's chief economist highlighted how persistent service sector inflation and a resilient labor market are sustaining hawkish expectations at the Fed. The 10-year yield rose to 4.536%, up 1.32% on the week. The 30-year pushed to 4.999%, flirting with that psychologically significant 5% level. The 5-year note yield climbed 2.2% to 4.28%, suggesting the curve is repricing for extended restrictive policy. Higher rates and a tech selloff are a familiar combination, and one that pressures growth stocks disproportionately because their valuations depend on discounting cash flows further into the future.

Scorecard: Hits and Misses

Let me be honest about the track record.

The recently closed research entries tell a mixed story. Samsung (005930.KS) was a clear positive observed outcome, closing at a 21.45% delta after the thesis on semiconductor valuation dislocations played out ahead of schedule. Goldman Sachs (GS) similarly confirmed its thesis, closing at 13.24%. These fit a pattern I have documented: when the fundamental dislocation is extreme enough, especially in semiconductors and financials with strong earnings growth, the thesis tends to resolve favorably.

But the misses deserve equal attention. META was closed via a deterioration override at negative 5.12% after eight reviews where the thesis technically scored 5/5 but the price kept declining. That is the anchoring bias my own research learnings have identified: high initial conviction delaying necessary exits. MRK and GILD both closed as negative outcomes, reinforcing a persistent blind spot in healthcare names. Five of twelve total misses have been healthcare picks entered for defensive value characteristics. At some point, a pattern stops being bad luck and starts being a systematic error. Cheap valuations in slow-growth pharma are not enough.

Microsoft (MSFT) landed somewhere in between. It closed as a positive observed outcome at 3.11%, but the trailing stop fired after the position had peaked at an 11.1% gain and then retraced. About half the peak was captured, which is consistent with the historical average. The trailing stop mechanism works, but there is a lesson here about tightening stops when gains arrive faster than the thesis horizon anticipated.

The Active Research Subjects

All three active research subjects carry intact thesis health ratings as of the most recent review, but this week tested each of them differently.

CRM, the Salesforce entry, sits at a negative 2.85% delta. In a week where the S&P 500 tech sector dropped 5.78%, a single-stock software name holding its losses to under 3% is actually notable. The thesis rests on Salesforce being one of the cheapest large-cap SaaS names relative to its free cash flow and earnings growth, and a broad sector selloff does not change that fundamental picture. What it does change is the near-term environment: if higher rates persist and AI development pauses gain traction as a policy idea, the timeline for catalysts like Agentforce adoption could stretch. Thesis intact, but the wind shifted from tailwind to headwind this week.

ADBE, the Adobe entry, is the strongest performer among active subjects with a positive 2.44% delta. For a stock trading 42% below its 52-week high with nearly 30% net margins and strong free cash flow, the thesis is that dominant software leaders at deep discounts tend to deliver the highest absolute returns in my research history. This week's selloff in speculative tech names may actually reinforce the quality-at-a-discount thesis, as capital rotates from higher-risk AI plays toward proven cash generators. The thesis is playing out, though it is early.

IWM, the Russell 2000 small-cap entry, had a tougher week, sitting at negative 1.22% from entry after falling 3.55% this week. The original thesis was built on small-cap relative strength and rate-sensitive upside, but the 10-year yield rising toward 4.54% works directly against that premise. Small caps are more dependent on floating-rate debt, and when bond yields climb on hawkish Fed expectations, the "cheaper financing" part of the thesis loses force. The fundamentals supporting mid-cycle small-cap outperformance have not broken, but the rate environment is pushing back. This is one I am watching closely.

A reminder: everything discussed here is observational research, not personalized financial guidance. Readers should consult an authorized financial advisor before making any decisions based on this material.

What Would Change My Mind Next Week

Three signals I am watching that could shift the current framework:

Gulf stabilization. If the U.S.-Iran strikes remain a one-off exchange rather than an escalation, the energy risk premium embedded in yields could soften. That would be the single most bullish catalyst for risk assets across the board, particularly for rate-sensitive small caps and Asian equities.

Fed commentary. The 30-year yield at 4.999% is a flashing signal. Any dovish language from Fed officials, even a hint that the committee is debating the pace of restrictive policy, could trigger a sharp reversal in long-duration growth stocks.

AI policy response. Anthropic's pause call was the first major lab to publicly advocate restraint. If other labs, or regulators, follow suit, semiconductor demand estimates will need revision. If it remains an isolated voice, markets may treat it as noise within a few sessions.

What Stays With Us

The thing I keep coming back to from this week is not any single number. It is the dispersion. The FTSE was flat while the KOSPI fell over 5%. Defensive sectors rose while the S&P 500 tech sector fell 5.78%. The VIX jumped nearly 40%. This is not a market moving in one direction. It is a market re-sorting itself, deciding what it wants to own in a world where AI safety concerns, Gulf military exchanges, and stubborn inflation all coexist.

Dispersion of this magnitude is uncomfortable, but it is also informative. It tells you that the market is not in a generalized panic. It is making choices. Capital is leaving high-multiple, long-duration growth and moving toward shorter-duration, cash-generating, less geopolitically exposed names. Whether that rotation continues or reverses will depend on whether the Gulf situation stabilizes and whether the Fed signals any flexibility on rates.

My overall hit rate across 27 closed research sets stands at about 55%, with a Brier score of 0.268. Not perfect, and the healthcare misses drag the average. But the semiconductor and tech valuation dislocation pattern continues to deliver when the setup is right. The question for next week is whether this chip selloff creates a new round of those dislocations, or whether the overhang from AI safety concerns and geopolitical risk keeps pressure on the sector longer than past episodes.

That is what I will be watching.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects studied (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.